Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Langley

Showing results (61-70 of 333) with videos related to

Pageof 34
Sort By:
The Quality Letter for Healthcare Leaders|August 5, 1997
Lessons from formulary decisionmakingP C Langley
The Annals of Pharmacotherapy|September 1, 1995
Comment: substantiation in pharmacoeconomic evaluationsP C Langley
Innovations in Pharmacy|May 19, 2021
To Dream the Impossible Dream: The Commitment by the Institute for Clinical and Economic Review to Rewrite the Axioms of Fundamental Measurement for Hemophilia A and Bladder Cancer Value ClaimsPaul C Langley
Innovations in Pharmacy|May 19, 2021
Outcomes, Registries and Medical Marijuana: Towards Establishing Dispensary Monitoring and Reporting StandardsPaul C Langley
Innovations in Pharmacy|May 19, 2021
ICER, ISPOR AND QALYs: Tales of Imaginary WorldsPaul C Langley
Innovations in Pharmacy|May 19, 2021
Value Assessment in Cystic Fibrosis: ICER's Rejection of the Axioms of Fundamental MeasurementPaul C Langley
Innovations in Pharmacy|May 19, 2021
The Impossible QALY and the Denial of Fundamental Measurement: Rejecting the University of Washington Value Assessment of Targeted Immune Modulators (TIMS) in Ulcerative Colitis for the Institute for Clinical and Economic Review (ICER)Paul C Langley
Innovations in Pharmacy|May 21, 2021
More Unnecessary Imaginary Worlds - Part 3: Cystic Fibrosis and the Institute for Clinical and Economic Review's Draft Evidence ReportPaul C Langley
Innovations in Pharmacy|June 12, 2023
Rasch Measurement and Patient Reported Value Claims: A Primer for HemophiliaPaul C Langley
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|November 16, 2021
Nutrition screening tools: Still no consensus 40 years onSimon C Langley-Evans
Pageof 34

Showing results (61-70 of 333) with videos related to

Sort By:
Pageof 34
The Quality Letter for Healthcare Leaders|August 5, 1997
Lessons from formulary decisionmakingP C Langley
The Annals of Pharmacotherapy|September 1, 1995
Comment: substantiation in pharmacoeconomic evaluationsP C Langley
Innovations in Pharmacy|May 19, 2021
To Dream the Impossible Dream: The Commitment by the Institute for Clinical and Economic Review to Rewrite the Axioms of Fundamental Measurement for Hemophilia A and Bladder Cancer Value ClaimsPaul C Langley
Innovations in Pharmacy|May 19, 2021
Outcomes, Registries and Medical Marijuana: Towards Establishing Dispensary Monitoring and Reporting StandardsPaul C Langley
Innovations in Pharmacy|May 19, 2021
ICER, ISPOR AND QALYs: Tales of Imaginary WorldsPaul C Langley
Innovations in Pharmacy|May 19, 2021
Value Assessment in Cystic Fibrosis: ICER's Rejection of the Axioms of Fundamental MeasurementPaul C Langley
Innovations in Pharmacy|May 19, 2021
The Impossible QALY and the Denial of Fundamental Measurement: Rejecting the University of Washington Value Assessment of Targeted Immune Modulators (TIMS) in Ulcerative Colitis for the Institute for Clinical and Economic Review (ICER)Paul C Langley
Innovations in Pharmacy|May 21, 2021
More Unnecessary Imaginary Worlds - Part 3: Cystic Fibrosis and the Institute for Clinical and Economic Review's Draft Evidence ReportPaul C Langley
Innovations in Pharmacy|June 12, 2023
Rasch Measurement and Patient Reported Value Claims: A Primer for HemophiliaPaul C Langley
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|November 16, 2021
Nutrition screening tools: Still no consensus 40 years onSimon C Langley-Evans
Pageof 34